Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:dextroamphetamine
amphetamine |
| gptkbp:broadcastOn |
Schedule II controlled substance (US)
|
| gptkbp:drugClass |
stimulant
|
| https://www.w3.org/2000/01/rdf-schema#label |
Endura-D
|
| gptkbp:marketedAs |
gptkb:Richwood_Pharmaceuticals
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
loss of appetite
increased heart rate insomnia |
| gptkbp:usedFor |
treatment of ADHD
treatment of narcolepsy |
| gptkbp:bfsParent |
gptkb:Ford_diesel_engine
|
| gptkbp:bfsLayer |
7
|